British Medical Bulletin 52:778-786 (1996)
© 1996 The British Council
research-article |
Paediatric myelodysplasia
Department of Haematology and Oncology, Great Ormond Street Children's Hospital London, UK
I M Hann, Department of Haematology and Oncology, Great Ormond Street Children's Hospital, London WC1N 3JH, UK
Abstract
Myelodysplastic syndromes (MDS) in childhood comprise a heterogeneous group of disorders, many of which respond poorly to intensive chemotherapy; the only curative treatment for these is bone marrow transplant (BMT). There are, however, some types of paediatric MDS with a slower, more indolent course, and it is important to differentiate these and tailor treatment accordingly. The prognosis for children with MDS who have a matched sibling BMT is improving and, as experience of unrelated donor BMT is gained, this treatment modality is likely to become available for the majority of the remainder.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. A. Felix and B. J. Lange Leukemia in Infants Oncologist, June 1, 1999; 4(3): 225 - 240. [Abstract] [Full Text] |
||||
